121 related articles for article (PubMed ID: 2811064)
1. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.
Davies SJ; Suassuna J; Ogg CS; Cameron JS
Kidney Int; 1989 Oct; 36(4):661-8. PubMed ID: 2811064
[TBL] [Abstract][Full Text] [Related]
2. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Clin Immunol Immunopathol; 1990 Aug; 56(2):151-8. PubMed ID: 2379325
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent.
Brando B; Galato R; Seveso M; Sommaruga E; Busnach G; Minetti L
ASAIO Trans; 1988; 34(3):441-4. PubMed ID: 3264175
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CD25 and HLA-DR on lymphocytes recruited into the peritoneal cavity in non-infected CAPD patients.
Brauner A; Hylander B; Jacobson SH; Moshfegh A; Lundahl J
Inflammation; 2001 Dec; 25(6):399-404. PubMed ID: 11831443
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of monocytes and macrophages from CAPD patients.
Lewis SL; Norris PJ; Holmes CJ
ASAIO Trans; 1990; 36(3):M575-7. PubMed ID: 2252754
[TBL] [Abstract][Full Text] [Related]
6. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.
Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hoefsmit EC; Beelen RH
Kidney Int; 1993 Mar; 43(3):641-8. PubMed ID: 8455363
[TBL] [Abstract][Full Text] [Related]
7. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.
Brauner A; Lu Y; Halldén G; Hylander B; Lundahl J
Inflammation; 1998 Feb; 22(1):55-66. PubMed ID: 9484650
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
[TBL] [Abstract][Full Text] [Related]
9. Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD).
Moughal NA; McGregor SJ; Brock JH; Briggs JD; Junor BJ
Eur J Clin Invest; 1991 Dec; 21(6):592-6. PubMed ID: 1778220
[TBL] [Abstract][Full Text] [Related]
10. Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11b, CD14, CD16, and CD64 on peritoneal macrophages.
Cárcamo C; Fernández-Castro M; Selgas R; Jiménez C; Molina S; Vara F
Perit Dial Int; 1996; 16(6):582-9. PubMed ID: 8981525
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR expression on human peritoneal macrophages in vivo and in vitro.
Bos HJ; Keizer GD; vd Muijsenberg AJ; Beelen RH
Cell Biol Int Rep; 1990 Jun; 14(6):499-508. PubMed ID: 2196125
[TBL] [Abstract][Full Text] [Related]
12. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
[No Abstract] [Full Text] [Related]
13. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum.
Fricke H; Hartmann J; Sitter T; Steldinger R; Rieber P; Schiffl H
Kidney Int; 1996 May; 49(5):1386-95. PubMed ID: 8731104
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
Lamperi S; Carozzi S
Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
[TBL] [Abstract][Full Text] [Related]
15. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
Goldstein CS; Bomalaski JS; Zurier RB; Neilson EG; Douglas SD
Kidney Int; 1984 Nov; 26(5):733-40. PubMed ID: 6596459
[TBL] [Abstract][Full Text] [Related]
16. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.
van Bronswijk H; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Verhoef J
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):368-73. PubMed ID: 3137037
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cellular populations in peritoneal effluents of children on CAPD.
Valle MT; Degl'Innocenti ML; Giordano P; Kunkl A; Costantini MT; Perfumo F; Manca F; Gusmano R
Clin Nephrol; 1989 Nov; 32(5):235-8. PubMed ID: 2582649
[TBL] [Abstract][Full Text] [Related]
18. Normal human immune peritoneal cells: subpopulations and functional characteristics.
Kubicka U; Olszewski WL; Tarnowski W; Bielecki K; Ziółkowska A; Wierzbicki Z
Scand J Immunol; 1996 Aug; 44(2):157-63. PubMed ID: 8711429
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
Lewis SL; Bonner PN; Cooper CL; Holmes CJ
J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
[TBL] [Abstract][Full Text] [Related]
20. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
Lin CY; Ku WL; Huang TP
Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
